CVS HEALTH CORPORATION (CVS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 87.04B USD | Liabilities, Current |
| Cash and equivalents | 11.33B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 40.31B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 17.62B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $87.04B | $11.33B | (m) | $40.31B | $17.62B | (m) |
| 2026-03-31 | (m) | $86.41B | $9.54B | (m) | $40.99B | $17.77B | (m) |
| 2025-12-31 | (m) | $88.69B | $8.45B | (m) | $39.78B | $19.25B | (m) |
| 2025-09-30 | (m) | $92.69B | $9.10B | (m) | $43.86B | $18.96B | (m) |
| 2025-06-30 | (m) | $94.16B | $11.79B | (m) | $40.65B | $17.45B | (m) |
| 2025-03-31 | (m) | $88.96B | $10.08B | (m) | $39.63B | $17.39B | (m) |
| 2024-12-31 | (m) | $84.61B | $8.59B | (m) | $36.47B | $18.11B | (m) |
| 2024-09-30 | (m) | $84.63B | $6.88B | (m) | $36.18B | $17.65B | (m) |
| 2024-06-30 | (m) | $81.39B | $12.51B | (m) | $32.38B | $16.07B | (m) |
| 2024-03-31 | (m) | $83.32B | $9.80B | (m) | $32.22B | $16.35B | (m) |
| 2023-12-31 | (m) | $79.19B | $8.20B | (m) | $35.23B | $18.02B | (m) |
| 2023-09-30 | (m) | $81.55B | $13.04B | (m) | $32.93B | $17.95B | (m) |
| 2023-06-30 | (m) | $79.21B | $13.81B | (m) | $29.55B | $17.29B | (m) |
| 2023-03-31 | (m) | $75.05B | $14.62B | (m) | $28.33B | $18.26B | (m) |
| 2022-12-31 | (m) | $69.74B | $12.95B | (m) | $27.28B | $19.09B | (m) |
| 2022-09-30 | (m) | $72.41B | $17.20B | (m) | $26.32B | $18.06B | (m) |
| 2022-06-30 | (m) | $68.46B | $12.12B | (m) | $27.23B | $17.38B | (m) |
| 2022-03-31 | (m) | $69.78B | $8.44B | (m) | $26.45B | $18.16B | (m) |
| 2021-12-31 | (m) | $67.81B | $9.41B | (m) | $24.43B | $17.76B | (m) |
| 2021-09-30 | (m) | $64.71B | $9.83B | (m) | $25.28B | $17.40B | (m) |
| 2021-06-30 | (m) | $59.31B | $7.12B | (m) | $24.16B | $16.98B | (m) |
| 2021-03-31 | (m) | $60.10B | $5.60B | (m) | $23.86B | $17.62B | (m) |
| 2020-12-31 | (m) | $62.02B | $7.85B | (m) | $21.74B | $18.50B | (m) |
| 2020-09-30 | (m) | $62.04B | $9.26B | (m) | $23.82B | $17.48B | (m) |
| 2020-06-30 | (m) | $63.69B | $14.87B | (m) | $22.52B | $16.52B | (m) |
| 2020-03-31 | (m) | $59.56B | $10.08B | (m) | $23.04B | $16.98B | (m) |
| 2019-12-31 | (m) | $53.30B | $5.68B | (m) | $19.62B | $17.52B | (m) |
| 2019-09-30 | (m) | $52.54B | $5.19B | (m) | $19.79B | $16.03B | (m) |
| 2019-06-30 | (m) | $49.38B | $6.06B | (m) | $18.17B | $15.51B | (m) |
| 2019-03-31 | (m) | $50.63B | $5.90B | (m) | $19.51B | $15.45B | (m) |
| 2019-01-01 | (m) | $45.76B | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $24.05B | $44.01B | $4.06B | $2.36B | $17.63B | $16.45B | 0.55× |
| 2018-09-30 | (m) | $29.46B | $41.59B | (m) | $14.84B | $14.82B | (m) |
| 2018-06-30 | (m) | $31.49B | $43.81B | (m) | $14.16B | $14.92B | (m) |
| 2018-03-31 | (m) | $30.25B | $42.02B | (m) | $13.96B | $14.82B | (m) |
| 2017-12-31 | (m) | $30.65B | $1.70B | (m) | $13.18B | $15.30B | (m) |
| 2017-09-30 | (m) | $28.51B | $2.48B | (m) | $12.44B | $14.15B | (m) |
| 2017-06-30 | (m) | $26.86B | $2.09B | (m) | $12.27B | $14.27B | (m) |
| 2017-03-31 | (m) | $27.29B | $2.22B | (m) | $12.11B | $14.31B | (m) |
| 2016-12-31 | (m) | $26.25B | $3.37B | (m) | $12.16B | $14.76B | (m) |
| 2016-09-30 | (m) | $26.74B | $2.19B | (m) | $13.63B | $14.35B | (m) |
| 2016-06-30 | (m) | $26.57B | $1.13B | (m) | $13.18B | $14.18B | (m) |
| 2016-03-31 | (m) | $24.54B | $1.78B | (m) | $13.03B | $13.91B | (m) |
| 2015-12-31 | (m) | $23.17B | $2.46B | (m) | $11.89B | $14.00B | (m) |
| 2015-09-30 | (m) | $21.43B | $2.89B | (m) | $12.80B | $13.28B | (m) |
| 2015-06-30 | (m) | $20.39B | $1.24B | (m) | $10.89B | $12.38B | (m) |
| 2015-03-31 | (m) | $19.71B | $1.52B | (m) | $10.16B | $12.23B | (m) |
| 2014-12-31 | (m) | $19.03B | $2.48B | (m) | $9.69B | $11.93B | (m) |
| 2014-09-30 | (m) | $18.21B | $1.13B | (m) | $10.83B | $11.61B | (m) |
| 2014-06-30 | (m) | $16.63B | $1.61B | (m) | $9.53B | $11.36B | (m) |
| 2014-03-31 | (m) | $16.21B | $2.77B | (m) | $9.09B | $11.19B | (m) |
| 2013-12-31 | (m) | $15.43B | $4.09B | (m) | $8.73B | $11.04B | (m) |
| 2013-09-30 | (m) | $15.10B | $1.50B | (m) | $8.04B | $10.82B | (m) |
| 2013-06-30 | (m) | $12.69B | $1.17B | (m) | $7.09B | $10.58B | (m) |
| 2013-03-31 | (m) | $13.20B | $1.55B | (m) | $6.63B | $10.59B | (m) |
| 2012-12-31 | (m) | $13.79B | $1.38B | (m) | $6.47B | $10.76B | (m) |
| 2012-09-30 | (m) | $13.26B | $1.23B | (m) | $6.41B | $10.49B | (m) |
| 2012-06-30 | (m) | $13.14B | $1.82B | (m) | $6.12B | $10.43B | (m) |
| 2012-03-31 | (m) | $13.41B | $2.21B | (m) | $6.11B | $10.68B | (m) |
| 2011-12-31 | (m) | $11.96B | $1.41B | (m) | $6.05B | $10.05B | (m) |
| 2011-09-30 | (m) | $12.35B | $1.71B | (m) | $5.90B | $10.38B | (m) |
| 2011-06-30 | (m) | $11.75B | $2.23B | (m) | $5.89B | $10.11B | (m) |
| 2011-03-31 | (m) | $11.46B | $2.16B | (m) | $5.35B | $10.18B | (m) |
| 2010-12-31 | (m) | $11.07B | $1.43B | (m) | $4.92B | $10.70B | (m) |
| 2010-09-30 | (m) | $11.67B | $979.00M | (m) | $5.11B | $10.59B | (m) |
| 2010-06-30 | (m) | $11.46B | $1.11B | (m) | $5.10B | $10.39B | (m) |
| 2010-03-31 | (m) | $12.34B | $1.05B | (m) | $5.15B | $10.28B | (m) |
| 2009-12-31 | (m) | $12.30B | $1.09B | (m) | $5.46B | $10.34B | (m) |
| 2009-09-30 | (m) | $12.70B | $1.13B | (m) | $5.69B | $9.98B | (m) |
| 2009-06-30 | (m) | $12.76B | $1.23B | (m) | $5.52B | $9.40B | (m) |
| 2009-03-31 | (m) | (m) | $997.00M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $13.49B | $1.35B | (m) | $5.38B | $9.15B | (m) |
| 2008-09-27 | (m) | (m) | $1.28B | (m) | (m) | (m) | (m) |
| 2008-06-28 | (m) | (m) | $615.70M | (m) | (m) | (m) | (m) |
| 2007-12-29 | (m) | (m) | $1.06B | (m) | (m) | (m) | (m) |
| 2006-12-30 | (m) | (m) | $530.00M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |